As the healthcare and pharmaceutical industry continues to innovate life-saving medicines and vaccines for better patient outcomes, it is essential that sustainable efforts remain at the forefront of...
This agreement will see InnoBation Bio develop and manufacture clinical trial sample substances of an anti-CD47 antibody. GenScript ProBio, a global biopharmaceutical contract development and...
With the rights to human iPSC technology, SCG can mass-produce off-the-shelf natural killer cell therapy, making it more affordable and accessible to patients. Singapore-based SCG Cell Therapy Pte...
An interview with Liu Qun, Head of IQVIA Biotech, China, on the Chinese biopharmaceutical market. China has been an increasingly attractive market for pharmaceuticals in recent years. What makes the...
CBC group, a healthcare-dedicated investment platform, together with Everest Medicines announced on 9 October 2020 the initial public offering of the late clinical-stage biopharmaceutical company....
Mundipharma enters into partnership with Samsung Bioepis to broaden reach of biosimilars to Taiwan and Hong Kong. Mundipharma, an independent network of companies announced on 13th January 2020 that...
Gilead Sciences announced in November 2019 the recipients of its 2019 Gilead Asia Pacific Rainbow Grant Programme. The research-based bio-pharmaceutical company, Gilead Sciences, announced in...
Four years after the initiation of an extensive regulatory reform to accelerate new drug approvals, the Chinese legislature finally passed the new Drug Administration Law (DAL) on August 26, 2019,...
New research group launched by SMART, Critical Analytics for Manufacturing Personalized-Medicine (CAMP) as part of Singapore’s National Cell Manufacturing Initiative. Cell therapies currently face...
Hangzhou plans to be bio-pharmaceutical innovation city. Hangzhou, capital of east China's Zhejiang Province, is becoming a magnet for bio-pharmaceutical enterprises both in China and abroad....
